OSR Health, Inc. Common Stock
OSRHStock
$0.49−60.34%52W
Market Cap$17.05M
P/E—
Div yield—
Beta0.70
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-42.62%
Price vs S&P 500 (4W)11.96%
VGM Score29.51
Market Capitalization$17.05M
Earnings Surprise History
Q4 25-0.16est. -0.10
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OSRHOSR Health, Inc. Common Stock | C | F | D | $0.49 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
OSR Holdings Inc operates in three healthcare segments: oral immunotherapy development for cancer, design-augmented biologics for age-related and degenerative diseases, and neurovascular medical device distribution in Korea. The company develops and commercializes therapeutic and medical device solutions to improve patient outcomes.